Telix Pharmaceuticals Limited
TLX · ASX · AUD
A$15.40
−0.33 −2.10%todayNot financial advice.
- Open
- 15.38
- Day range
- 14.83 - 15.47
- 52-week range
- 8.26 - 18.22
- Volume
- 1.11M
- Market cap
- 3.72B
- P/E ratio
- 117.47
- EPS
- 0.1
- Dividend yield
- 0.00%
- Beta
- 1.09
Performance
W
−3.45%
1M
−12.35%
3M
−0.65%
6M
+7.92%
YTD
+36.89%
Y
−7.34%
5Y
+167.83%
All
+1,801.23%
In the news
Oct 19
Telix Pharmaceuticals Partners With Ekalia for U.S. Astatine-211 Isotope Supply
Telix Pharmaceuticals is partnering with Ekalia to establish U.S. production of astatine-211 to support its brain cancer therapy pipeline.
Company news
Oct 19
Telix Pharmaceuticals Partners With Ekalia to Expand U.S. Astatine-211 Isotope Production
Telix Pharmaceuticals collaborates with Ekalia to produce astatine-211 in the U.S., securing supply for its cancer therapy programs.
Company news
Oct 19
Ekalia Partners With Telix to Expand U.S. Radioisotope Production
Telix Pharmaceuticals (ASX:TLX) will help Ekalia commission its first U.S. Astatine-211 unit to secure isotope supply for targeted alpha therapies.
Company news
Embed on your site
Embed docsAdd a live price card or a chart to any page. Free, no sign-up; cards refresh every minute and link back here.
<iframe src="https://stocks.freetheai.org/embed/ASX-TLX" width="340" height="170" style="border:0;max-width:100%" loading="lazy" title="Telix Pharmaceuticals Limited (TLX) - FreeTheAI Stocks"></iframe>
<p style="font-size:12px"><a href="https://stocks.freetheai.org/symbols/ASX-TLX">TLX stock price</a> by FreeTheAI Stocks</p>